Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes

Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes

Hiroyuki Ito1, Suzuko Matsumoto1, Takuma Izutsu1, Eiji Kusano1, Shinya Nishio1, Shinichi Antoku1, Tomoko Yamasaki1, Toshiko Mori1, Michiko Togane1, Shigenori Ando2, Emiko Tsugami2 1Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan; 2Department of Pharmacy, Edogawa...

Full description

Bibliographic Details
Main Authors: Ito H, Matsumoto S, Izutsu T, Kusano E, Nishio S, Antoku S, Yamasaki T, Mori T, Togane M, Ando S, Tsugami E
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
sodium-glucose cotransporter 2 inhibitor
empagliflozin
type 2 diabetes mellitus
elderly
renoprotection
renal impairment
Online Access:https://www.dovepress.com/comparison-of-the-changes-in-the-factors-associated-with-the-renal-pro-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/comparison-of-the-changes-in-the-factors-associated-with-the-renal-pro-peer-reviewed-article-DMSO

Similar Items